(SRPT) Sarepta Therapeutics - Performance -89.1% in 12m
SRPT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-65.05%
#91 in Peer-Group
Rel. Strength
1.59%
#7297 in Stock-Universe
Total Return 12m
-89.09%
#191 in Peer-Group
Total Return 5y
-89.49%
#111 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 9.84 |
| High / Low | USD |
|---|---|
| 52 Week High | 158.00 USD |
| 52 Week Low | 17.10 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 15.69 |
| Buy/Sell Signal +-5 | -0.72 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: SRPT (-89.1%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: SRPT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SRPT
| Total Return (including Dividends) | SRPT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -54.69% | 2.09% | 4.55% |
| 3 Months | -73.21% | 2.27% | 10.78% |
| 12 Months | -89.09% | -10.84% | 14.71% |
| 5 Years | -89.49% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | SRPT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -88.4% | 18.8% | 79.2% |
| 3 Months | -80% | 71.5% | 92.9% |
| 12 Months | -94.8% | -84.3% | 44.2% |
| 5 Years | 3.8% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th0.50 | -55.62% | -56.66% |
| 3 Month | %th0.50 | -73.80% | -75.81% |
| 12 Month | %th5.00 | -87.76% | -90.49% |
| 5 Years | %th44.00 | -85.75% | -95.06% |
FAQs
Does Sarepta Therapeutics (SRPT) outperform the market?
No,
over the last 12 months SRPT made -89.09%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months SRPT made -73.21%, while XBI made 2.27%.
Performance Comparison SRPT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
SRPT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -12.3% | -59.2% | -92% | -104% |
| US NASDAQ 100 | QQQ | -13.1% | -60.2% | -94.1% | -104% |
| German DAX 40 | DAX | -12.2% | -54.7% | -104.9% | -119% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -12% | -58.9% | -90% | -107% |
| Hongkong Hang Seng | HSI | -11.9% | -60.5% | -107.7% | -125% |
| India NIFTY 50 | INDA | -11.9% | -56.8% | -91.7% | -89% |
| Brasil Bovespa | EWZ | -13.7% | -62.5% | -116.5% | -102% |
SRPT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -13.9% | -61.5% | -98.7% | -118% |
| Consumer Discretionary | XLY | -10.8% | -56.3% | -83.3% | -109% |
| Consumer Staples | XLP | -8.9% | -53.1% | -90.2% | -98% |
| Energy | XLE | -8% | -58.2% | -86.5% | -85% |
| Financial | XLF | -12.4% | -57.8% | -95.1% | -118% |
| Health Care | XLV | -11.4% | -56.7% | -84.8% | -84% |
| Industrial | XLI | -11.9% | -58.4% | -98.6% | -113% |
| Materials | XLB | -10.4% | -56.3% | -91.3% | -92% |
| Real Estate | XLRE | -7.9% | -54.7% | -89.4% | -102% |
| Technology | XLK | -13.6% | -63.6% | -95.2% | -101% |
| Utilities | XLU | -9.9% | -54.8% | -95.4% | -113% |
| Aerospace & Defense | XAR | -14.3% | -64.6% | -113.4% | -142% |
| Biotech | XBI | -10.2% | -56.8% | -78% | -78% |
| Homebuilder | XHB | -10.6% | -60.8% | -80.7% | -90% |
| Retail | XRT | -9.2% | -56.1% | -83.3% | -95% |
SRPT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -5.1% | -59.8% | -82.7% | -79% |
| Natural Gas | UNG | -0.1% | -45.3% | -76.8% | -81% |
| Gold | GLD | -7.4% | -52.5% | -111.8% | -131% |
| Silver | SLV | -8.9% | -58.6% | -110.6% | -111% |
| Copper | CPER | -12.6% | -58.9% | -111.7% | -104% |
SRPT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -11.1% | -58.3% | -88.8% | -91% |
| iShares High Yield Corp. Bond | HYG | -10.3% | -56.6% | -91% | -100% |